Menu Back to 10th-Annual-Forum-for-Qualified-Persons-in-Pharmacovigilance

Overview

This is the only forum designed for QPPVs by QPPVs, now in its 10th year and ever growing. This year’s objectives, as shown below, build on past successes and have been shaped by valuable feedback provided by participants of the past nine meeting, plus will celebrate a decade of QPPV and Regulator interaction through this Forum.

Over time, one of the key successes of the Forum has been the ability to secure continuing support and involvement of key regulators. Sessions have been open and interactive with attendees appreciating opportunities to raise challenging issues in an informal environment. This 10th QPPV Forum aims to continue to attract such key speakers and encourage open debate.

This year, there will be an enhanced opportunity for networking during a dinner which is included on the conference fee. Grab the opportunity to engage with the QPPV community!

Who should attend?

  • EU QPPVs and Deputies (present or aspiring), regardless of company size
  • Pharmacovigilance Regulators and Inspectors
  • CRO and Consultants providing QPPV Services
  • National Responsible Persons for Pharmacovigilance
  • Quality Management Personnel
  • Heads of Pharmacovigilance
  • Other stakeholders supporting the EU QPPV

Learning objectives

  • Hear the latest updates and hot topics relating to the role of the QPPV
  • Explore long term PV visions, future directions of the ‘PV world’, and potential impact on the role of QPPV
  • Network with colleagues and meet regulators
  • Learn from and share experience and ideas with like-minded QPPVs in a neutral environment
  • Take away practical hints and tips
  • Better understand regulatory and inspectorate expectations of the QPPV
  • Identify the expanded expectations of the role in the context of the new regulatory framework and transparency initiatives
  • Examine current areas of real challenge

Program Committee

  • Vicki  Edwards, RPh
    Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and QPPV
    AbbVie, Inc., United Kingdom
  • Margaret Anne Walters
    Margaret Anne Walters Deputy EU Qualified Person for Pharmacovigilance
    Merck, Sharp & Dohme Ltd, United Kingdom
  • Barbara  De Bernardi, MD
    Barbara De Bernardi, MD Deputy EU QPPV and European Safety Office Head
    Pfizer Italia S.r.l., Italy
  • Peter  De Veene, MD
    Peter De Veene, MD QPPV
    Alexion, France
  • Brian  Edwards, DrMed
    Brian Edwards, DrMed Principal Consultant, Pharmacovigilance and Drug Safety, Vice-President ACRES
    NDA Group, United Kingdom
  • Elspeth  McIntosh
    Elspeth McIntosh Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Winrich  Rauschning, DrMed, MD, MBA
    Winrich Rauschning, DrMed, MD, MBA QPPV
    Biolitec Pharma, Germany
  • Michael  Richardson, MD, FFPM
    Michael Richardson, MD, FFPM International GPV&E and EU QPPV, Qualified Person for Pharmacovigilance
    Bristol-Myers Squibb, United Kingdom
  • Doris Irene Stenver, MD, MPA
    Doris Irene Stenver, MD, MPA Independent Pharmacovigilance Adviser
    Unique Advice, Denmark
Load More

Contact us

Registration Questions

Send Email
+41 61 225 51 51


Agenda and Logistics

Send Email
+41 61 225 51 49


Advertising Opportunities

Send Email
+41 61 225 51 51
Download Prospectus

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download